Tuesday, 30 April 2019
Regeneus ramps up global focus with addition of industry leaders
Article from STOCKHEAD
Regenerative medicine company Regeneus has secured seasoned industry leaders to its board as it looks to make bigger noise overseas.
News archive - 2019
- Wednesday, 30 January 2019
Regeneus' newly-appointed CEO Leo Lee discusses strategic plans for growth
Interview with Proactive Investors
Leo Lee, the newly-appointed CEO of Regeneus Ltd (ASX:RGS), speaks to Proactive Investors about the Australian clinical-stage regenerative medicine company's operations, and the wider scientific field.